Epitalon Overview, Dosing & Safety | Peptide Database
Epitalon (Epithalon) Synthetic Pineal Tetrapeptide | Telomerase Activator Community Research Join others researching Epitalon — share findings, ask questions, and learn from real experiences Epitalon is a synthetic tetrapeptide developed by Russian scientist V
Epitalon (Epithalon)
Synthetic Pineal Tetrapeptide | Telomerase Activator
Community Research
Join others researching Epitalon — share findings, ask questions, and learn from real experiences
Epitalon is a synthetic tetrapeptide developed by Russian scientist Vladimir Khavinson with 35+ years of research. It activates telomerase at extremely low concentrations to maintain telomere length, stimulates melatonin production, and modulates gene expression through epigenetic mechanisms.
Activates telomerase at extremely low concentrations (10⁻¹⁷ to 10⁻¹⁵ M) to maintain telomere length, stimulates melatonin production from the pineal gland, and modulates gene expression through epigenetic mechanisms.
Molecular Data
Alanine
Position 1
Glutamic Acid
Position 2
Aspartic Acid
Position 3
Glycine
Position 4
Research Indications
Activates telomerase at microgram doses to extend telomeres and cellular replicative lifespan.
Reverses aging markers and improves mitochondrial function at the cellular level.
Animal studies show 25-33% lifespan increases using 30-40mcg/kg doses.
Restores pineal gland function and circadian melatonin rhythm in elderly.
Supports new neuron formation at nanogram concentrations.
90% response rate for retinal degeneration at 5mcg per eye dosing.
Supports thymus gland regeneration for improved immune function.
Enhanced immune surveillance and countering of immunosenescence.
Dosing Protocols
Subcutaneous injection is the primary and most researched route. Short cycles of 10-20 days with 4-6 month breaks between cycles.
Standard anti-aging
200-500mcg
1x daily for 10-20 days
SubQ
Conservative start
100mcg
Russian clinical equivalent
300mcg
Ultra-low dose
50mcg
Reconstitution Instructions
Epitalon lyophilized powder vial (typically 10mg)
Bacteriostatic water (5mL creates 2mg/mL)
Insulin syringes (0.3mL for accurate microgram dosing)
Alcohol swabs
Sterile work surface
1 Clean vial tops with alcohol swabs
2 Add 5mL bacteriostatic water to 10mg vial (creates 2mg/mL)
3 Inject water slowly at vial side wall
4 Gently swirl - do not shake vigorously
5 Solution should be clear and colorless
6 Refrigerate immediately
7 Use 0.3mL insulin syringes for accurate microgram dosing
8 Use within 30 days of reconstitution
Protocol Variations
Multiple approaches exist - compare before choosing
Different sources recommend different protocols for this peptide. Review each approach and consider your goals, tolerance, and experience level before choosing.
Research-Based Low Dose
Source: Published Clinical Studies
"Use doses validated in peer-reviewed human research"
Based on actual human clinical trials, including a study of 75 women using 0.5mg/day sublingually for 20 days. Animal studies typically used 0.1-10mcg/mouse/day. This approach prioritizes evidence-based dosing over anecdotal community protocols.
Key Points
0.5-1mg daily (10-20x lower than community protocols)
Supported by peer-reviewed human clinical data
20-day cycle length from clinical trials
More economical per cycle
Aligns with research showing microgram-level efficacy
Dosing Schedule
High-Dose Community Protocol
Source: Biohacking Communities
"Higher doses for potentially stronger effects"
Widely circulated protocol recommending 5-10mg daily injections. This dosing lacks peer-reviewed human clinical data and may stem from translation errors of Russian research or extrapolation from other peptides. No published studies validate this dose range in humans.
5-10mg daily (10-20x higher than research protocols)
No peer-reviewed human data at these doses
Significantly more expensive per cycle
Unknown if higher doses provide additional benefit
May have originated from translation errors
Interactions
What to Expect
Side Effects & Safety
Common Side Effects
Generally well-tolerated with minimal side effects
Mild injection site reactions
Vivid dreams (melatonin-related)
Possible mild digestive upset (oral route)
Stop Signs - Discontinue if:
Signs of allergic reaction
Persistent injection site inflammation
New or changing moles (monitor skin)
Cancer diagnosis (discontinue immediately)
Unusual fatigue or weakness
Contraindications
Active malignancy (telomerase activation concern)
Chronic sinusitis (nasal route)
Known peptide allergies
Pregnancy or breastfeeding
Quality Checklist
Good Signs
White to off-white lyophilized powder
Clear, colorless solution when reconstituted
Certificate of analysis available (>98% purity)
Medical-grade pharmaceutical appearance
Proper cold-chain shipping
Warning Signs
Widespread dosing misinformation exists
Many sources recommend 5-10mg based on translation errors
Original research demonstrates microgram efficacy
Verify supplier credentials carefully
Bad Signs
Yellow or discolored powder (degradation)
Cloudy solution after mixing (contamination)
Missing or questionable sourcing documentation
Frequently Asked Questions
What's the correct Epitalon dosage—why do some sources recommend 5-10mg versus 0.5-1mg?
Peer-reviewed human clinical trials show efficacy at 0.5-1mg daily, while many community protocols recommend 5-10mg based on what appears to be translation errors from animal studies. Original research demonstrates microgram-level activation of telomerase, making lower doses research-supported. Higher doses lack human validation and are significantly more expensive.
Does Epitalon really extend lifespan or is that just animal studies?
Animal studies show 25-33% lifespan extension with Epitalon, and a 6-8 year clinical trial of 266 elderly subjects found a 1.6-1.8 fold mortality reduction with Epithalamin. While impressive, human lifespan extension claims remain theoretical. Effects on cellular aging markers like telomere length are better documented than actual longevity in humans.
Should I worry about Epitalon and cancer risk given telomerase activation?
Telomerase activation theoretically carries cancer risk, which is why Epitalon is contraindicated in active malignancy. However, 35+ years of research shows no increased cancer incidence in clinical trials. The key distinction: Epitalon activates telomerase in normal cells while cancer cells already have telomerase; the mechanism appears selective for aging cells.
How long after an Epitalon cycle do benefits persist?
Effects persist for months after a 10-20 day cycle due to epigenetic changes in gene expression and sustained telomerase activity. Many users repeat cycles 2-3 times yearly with 4-6 month breaks, allowing the body to maintain benefits from each cycle while avoiding continuous stimulation.
References
Addition of epithalon to telomerase-negative human fetal fibroblast culture induced expression of catalytic subunit (hTERT), enzymatic activity of telomerase, and telomere elongation. Extended replicative lifespan of cells.
Clinical trial of 266 elderly subjects over 6-8 years: Epithalamin reduced mortality 1.6-1.8 fold. Combined Thymalin + Epithalamin treatment for 6 years reduced mortality 4.1-fold vs control with improved cardiovascular and immune parameters.
Epitalon significantly stimulated melatonin synthesis in senescent monkeys during evening hours, normalizing circadian rhythm of cortisol secretion and restoring neuroendocrine regulation.
Epitalon therapy in patients with degenerative retinal lesions resulted in positive clinical effect in 90% of cases, intensifying bioelectric and functional activity of retina due to preservation of morphological structure.
Epitalon injected from 3 months until natural death increased maximum lifespan by 12.3% and last 10% survivors by 13.3%. Slowed age-related estrous function decline and reduced chromosome aberrations by 17.1%. Inhibited leukemia development 6-fold.
AEDG peptide increased neurogenic differentiation markers (Nestin, GAP43, β-Tubulin III, Doublecortin) 1.6-1.8 fold in human gingival mesenchymal stem cells. Molecular modelling showed preferential binding with H1/6 and H1/3 histones, suggesting epigenetic regulation.
Related Peptides
Enhanced immunomodulation - commonly combined in Russian protocols.
Different regenerative mechanisms.
Disclaimer
This information is for educational and research purposes only. Consult a healthcare professional before use.